BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26984177)

  • 1. p75 neurotrophin receptor expression is a characteristic of the mitotically quiescent cancer stem cell population present in esophageal squamous cell carcinoma.
    Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
    Int J Oncol; 2016 May; 48(5):1943-54. PubMed ID: 26984177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
    Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
    Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.
    Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY
    BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow Cytometric Detection of Circulating Tumor Cells Using a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR).
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Methods Mol Biol; 2017; 1634():211-217. PubMed ID: 28819854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal cell proliferation in the p75NTR-positive basal cell compartment of the esophageal epithelium during squamous carcinogenesis.
    Okumura T; Shimada Y; Sakurai T; Hori R; Nagata T; Sakai Y; Tsukada K
    Dis Esophagus; 2015 Oct; 28(7):634-43. PubMed ID: 24888722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
    Okumura T; Tsunoda S; Mori Y; Ito T; Kikuchi K; Wang TC; Yasumoto S; Shimada Y
    Clin Cancer Res; 2006 Sep; 12(17):5096-103. PubMed ID: 16951226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity.
    Li S; Yue D; Chen X; Wang L; Li J; Ping Y; Gao Q; Wang D; Zhang T; Li F; Yang L; Huang L; Zhang Y
    Oncol Rep; 2015 Jan; 33(1):425-32. PubMed ID: 25351876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
    Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
    J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
    Tsai ST; Wang PJ; Liou NJ; Lin PS; Chen CH; Chang WC
    PLoS One; 2015; 10(11):e0142834. PubMed ID: 26571024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells.
    Tong D; Sun J; Huang P; Li M; Zhang F
    Mol Med Rep; 2017 May; 15(5):2521-2529. PubMed ID: 28447720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
    Yang Z; Cui Y; Ni W; Kim S; Xuan Y
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-203 inhibits the progression of esophageal squamous cell carcinoma with restored epithelial tissue architecture in vivo.
    Okumura T; Shimada Y; Moriyama M; Takei Y; Omura T; Sekine S; Nagata T; Shimizu K; Tsukada K
    Int J Oncol; 2014 Jun; 44(6):1923-32. PubMed ID: 24692008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer.
    Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
    World J Surg Oncol; 2016 Feb; 14(1):40. PubMed ID: 26897248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma.
    Liu A; Zhu J; Wu G; Cao L; Tan Z; Zhang S; Jiang L; Wu J; Li M; Song L; Li J
    Mol Cancer; 2017 Jun; 16(1):106. PubMed ID: 28633632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma.
    Zhang HF; Wu C; Alshareef A; Gupta N; Zhao Q; Xu XE; Jiao JW; Li EM; Xu LY; Lai R
    Stem Cells; 2016 Aug; 34(8):2040-51. PubMed ID: 27144349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.